Recital 5, Regulation (EU) 2024/1892

In forcesince 10 Jul 2024

For the active substances thiencarbazone and valifenalate, the risk assessment pursuant to Article 11 of Implementing Regulation (EU) 2020/1740 has not yet been finalised by the respective rapporteur Member States.